Results 131 to 140 of about 46,198 (239)
Effects of Hydroxyurea on Development and Regeneration
HYDROXYUKEA is a potent inhibitor of DNA synthesis and mitosis1–6. It is known that it interferes with the reduction of ribonucleotides to deoxyribonucleotides1–4. It is bacteriostatic for Escherichia coli7, where it induces a reversible inhibition of DNA synthesis without affecting the synthesis of RNA and proteins.
openaire +3 more sources
Lost in the Vaso‐Occlusion: A Patient's Abdominal Pain Returns With a Vengeance
Pediatric Blood &Cancer, Volume 73, Issue 11, November 2026.
Dunia Hatabah +5 more
wiley +1 more source
ABSTRACT Objectives Polycythemia Vera (PV) is characterized by overproduction of erythrocytes, leading to a hypercoagulable state. Evidence regarding associations between PV and pregnancy outcomes is limited. The aim of our study was to provide robust evidence regarding the prevalence of pregnancy complications in women with PV.
Noah Margolese +5 more
wiley +1 more source
ABSTRACT Objective This study aimed to evaluate the feasibility and safety of venetoclax as a cytoreductive strategy during induction therapy in newly diagnosed acute promyelocytic leukemia (APL), and to provide an exploratory description of its early efficacy.
Yu Wang +3 more
wiley +1 more source
Hydroxyurea-induced melanonychia
Michael G. Buontempo, BS +6 more
openaire +3 more sources
Diabetes, Obesity and Metabolism, Volume 28, Issue 11, Page 9747-9752, November 2026.
Tomasz Klupa +14 more
wiley +1 more source
What's under the HAT?-clarifying HbS changes with combination hydroxyurea and transfusion for sickle cell disease. [PDF]
Nickel RS, Luban NLC, Webb J.
europepmc +1 more source
Hydroxyurea Use for Sickle Cell Disease Fact Sheet [PDF]
Hydroxyurea is an oral medicine that can help reduce sickle cell disease ...
core
Transfusion, Volume 66, Issue 11, Page 2397-2409, November 2026.
Nabiha H. Saifee +24 more
wiley +1 more source

